HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Steele, G. D. Articles by Menck, H. R. Search for Related Content PubMed PubMed Citation Articles by Steele, G. D., Jr Articles by Menck, H. R.

CA: A Cancer Journal for Clinicians, Vol 44, Issue 2 71-80, Copyright © 1994 by American Cancer Society

ARTICLES

Clinical highlights from the National Cancer Data Base: 1994

G. D. Steele Jr, R. T. Osteen, D. P. Winchester, G. P. Murphy and H. R. Menck
National Cancer Data Base, Boston, Massachusetts.

The National Cancer Data Base, a joint project of the American Cancer Society and the American College of Surgeons Commission on Cancer, provides a mechanism for periodic assessment of hospital-based cancer patient care. From the National Cancer Data Base's annual summary, health care professionals can evaluate trends in patient care to make more efficient treatment decisions. This article provides a first look at highlights from the 1994 annual summary.

This article has been cited by other articles:

				N. Petrelli Society of Surgical Oncology Heritage Award: Honoring Glenn D. Steele, Jr, MD, PhD Ann. Surg. Oncol., June 1, 2008; 15(6): 1553 - 1554. [Full Text] [PDF]

				R. P. Smith, S. B. Malkowicz, R. Whittington, K. VanArsdalen, Z. Tochner, and A. J. Wein Identification of Clinically Significant Prostate Cancer by Prostate-Specific Antigen Screening Arch Intern Med, June 14, 2004; 164(11): 1227 - 1230. [Abstract] [Full Text] [PDF]

				S. J. Miknyoczki, H. Chang, A. Klein-Szanto, C. A. Dionne, and B. A. Ruggeri The Trk Tyrosine Kinase Inhibitor CEP-701 (KT-5555) Exhibits Significant Antitumor Efficacy in Preclinical Xenograft Modelsof Human Pancreatic Ductal Adenocarcinoma Clin. Cancer Res., August 1, 1999; 5(8): 2205 - 2212. [Abstract] [Full Text] [PDF]

				G. S. Hagopian, G. B. Mills, A. R. Khokhar, R. C. Bast Jr., and Z. H. Siddik Expression of p53 in Cisplatin-resistant Ovarian Cancer Cell Lines: Modulation with the Novel Platinum Analogue (1R, 2R-Diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV) Clin. Cancer Res., March 1, 1999; 5(3): 655 - 663. [Abstract] [Full Text] [PDF]